Eslam M, Newsome PN, Sarin SK, Anstee QM, Targher G, Romero-Gomez M, et al. A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement. J Hepatol. 2020;73:202–209

Article  PubMed  Google Scholar 

Liu CJ, Chen PJ. Elimination of hepatitis B in highly endemic settings: lessons learned in Taiwan and challenges ahead. Viruses. 2020;12:815

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wong MCS, Huang JLW, George J, Huang J, Leung C, Eslam M, et al. The changing epidemiology of liver diseases in the Asia-Pacific region. Nat Rev Gastroenterol Hepatol. 2019;16:57–73

Article  PubMed  Google Scholar 

Vaz K, Clayton-Chubb D, Majeed A, Lubel J, Simmons D, Kemp W, et al. Current understanding and future perspectives on the impact of changing NAFLD to MAFLD on global epidemiology and clinical outcomes. Hepatol Int. 2023;17:1082–1097

Article  PubMed  Google Scholar 

Fan JG, Kim SU, Wong VW. New trends on obesity and NAFLD in Asia. J Hepatol. 2017;67:862–873

Article  PubMed  Google Scholar 

Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016;64:73–84

Article  PubMed  Google Scholar 

Yu ML, Chuang WL. Path from the discovery to the elimination of hepatitis C virus: honoring the winners of the nobel prize in physiology or medicine 2020. Kaohsiung J Med Sci. 2021;37:7–11

Article  Google Scholar 

Younossi ZM, Henry L, Janus PO, Tanaka A, Eguchi Y, Mizokami M, et al. Systematic review with meta-analysis: extrahepatic manifestations in chronic hepatitis C virus-infected patients in East Asia. Aliment Pharmacol Ther. 2019;49:644–653

Article  PubMed  Google Scholar 

World Health Organization. Global status report on alcohol and health 2018. https://www.who.int/publications/i/item/9789241565639 (2019). Accessed 1 Dec 2023.

Carvalho AF, Heilig M, Perez A, Probst C, Rehm J. Alcohol use disorders. Lancet. 2019;394(10200):781–792

Article  PubMed  Google Scholar 

Seto WK. Chronic hepatitis B and metabolic risk factors: a call for rigorous longitudinal studies. World J Gastroentrol. 2019;25:282–286

Article  Google Scholar 

Su HJ, Kao JH, Tseng TC, Yang HC, Su TH, Chen PJ, et al. Pathologic findings of patients with nonalcoholic fatty liver disease and the impact of concurrent hepatitis B virus infection in Taiwan. J Formos Med Assoc. 2020;119:1476–1482

Article  PubMed  Google Scholar 

Huang SC, Su HJ, Kao JH, Tseng TC, Yang HC, Su TH, et al. Clinical and histologic features of patients with biopsy-proven metabolic dysfunction-associated fatty liver disease. Gut Liver. 2021;15:451–458

Article  PubMed  PubMed Central  Google Scholar 

Åberg F, Puukka P, Salomaa V, Männistö S, Lundqvist A, Valsta L, et al. Combined effects of alcohol and metabolic disorders in patients with chronic liver disease. Clin Gastroenterol Hepatol. 2020;18:995–997

Article  PubMed  Google Scholar 

Wong VS, Wong GH, Chu WW, et al. Hepatitis B virus infection and fatty liver in the general population. J Hepatol. 2012;56:533–540

Article  PubMed  Google Scholar 

Sakhuja P, Kumar A, Hissar S, et al. Steatosis in chronic hepatitis B: prevalence and correlation with biochemical, histologic, viral, and metabolic parameters. Indian J Pathol Microbiol. 2011;54:454–459

Article  PubMed  Google Scholar 

Wang CC, Cheng PN, Kao JH. Systemic review: chronic viral hepatitis and metabolic derangement. Aliment Pharmacol Ther. 2020;51:216–230

Article  PubMed  Google Scholar 

Machado MV, Oliveira AG, Cortez-Pinto H. Hepatic steatosis in hepatitis B virus infected patients: meta-analysis of risk factors and comparison with hepatitis C infected patients. J Gastroenterol Hepatol. 2011;26:1361–1367

Article  PubMed  Google Scholar 

Joo EJ, Chang Y, Yeom JS, Ryu S. Hepatitis B virus infection and decreased risk of nonalcoholic fatty liver disease: a cohort study. Hepatology. 2017;65:828–835

Article  CAS  PubMed  Google Scholar 

Wong GL, Chan HL, Yu Z, Chan AW, Choi PC, Chim AM, et al. Coincidental metabolic syndrome increases the risk of liver fibrosis progression in patients with chronic hepatitis B–a prospective cohort study with paired transient elastography examinations. Aliment Pharmacol Ther. 2014;39:883–893

Article  CAS  PubMed  Google Scholar 

Yu MW, Lin CL, Liu CJ, Yang SH, Tseng YL, Wu CF. Influence of metabolic risk factors on risk of hepatocellular carcinoma and liver-related death in men with chronic hepatitis B: a large cohort study. Gastroenterology. 2017;153:1006–1017

Article  PubMed  Google Scholar 

Patmore LA, Katwaroe WK, van der Spek D, et al. Association between the presence of metabolic comorbidities and liver-related events in patients with chronic hepatitis B. Clin Gastroenterol Hepatol. 2023;21:3089–3096

Article  CAS  PubMed  Google Scholar 

Huang SC, Su TH, Tseng TC, et al. Distinct effects of hepatic steatosis and metabolic dysfunction on the risk of hepatocellular carcinoma in chronic hepatitis B. Hepatol Int. 2023;17:1139–1149

Article  PubMed  Google Scholar 

Huang SC, Su TH, Tseng TC, Chen CL, Hsu SJ, Liu CH, et al. Metabolic dysfunction-associated steatotic liver disease facilitates hepatitis B surface antigen seroclearance and seroconversion. Clin Gastroenterol Hepatol. 2023:S1542–3565(23)00842-X.

Ceylan B, Arslan F, Batırel A, Fincancı M, Yardımcı C, Fersan E, et al. Impact of fatty liver on hepatitis B virus replication and virologic response to tenofovir and entecavir. Turk J Gastroenterol. 2016;27:42–46

Article  PubMed  Google Scholar 

Yu JH, Lee JW. How does hepatic steatosis affect the outcome of patients with chronic hepatitis B? Clin Mol Hepatol. 2019;25:280–282

Article  PubMed  PubMed Central  Google Scholar 

Seto WK, Fung J, Cheung KS, Mak LY, Hui RW, Liu KS, et al. Body-mass index is associated with fibrosis regression during long-term nucleoside analogue therapy in chronic hepatitis B. Aliment Pharmacol Ther. 2016;44:1071–1079

Article  CAS  PubMed  Google Scholar 

Zhang Q, Zou B, Wu Y, Yeo Y, Wu H, Stave CD, et al. Systematic review with meta-analysis: prevalence of hepatic steatosis, fibrosis and associated factors in chronic hepatitis B. Aliment Pharmacol Ther. 2021;54:1100–1109

Article  Google Scholar 

Hu D, Wang H, Wang H, Wang Y, Wan X, Yan W, et al. Non-alcoholic hepatic steatosis attenuates hepatitis B virus replication in an HBV-immunocompetent mouse model. Hepatol Int. 2018;12:438–446

Article  PubMed  Google Scholar 

Liu Q, Mu M, Chen H, Zhang G, Yang Y, Chu Y, et al. Hepatocyte steatosis inhibits hepatitis B virus secretion via induction of endoplasmic reticulum stress. Mol Cell Biochem. 2022;477:2481–2491

Article  CAS  PubMed  Google Scholar 

Munteanu M, Tiniakos D, Anstee Q, Charlotte F, Marchesini G, Bugianesi E, et al. Diagnostic performance of FibroTest, SteatoTest and ActiTest in patients with NAFLD using the SAF score as histological reference. Aliment Pharmacol Ther. 2016;44:877–889

Article  CAS  PubMed  PubMed Central  Google Scholar 

Boursier J, de Ledinghen V, Leroy V, Anty R, Francque S, Salmon D, et al. A stepwise algorithm using an at-a-glance first-line test for the non-invasive diagnosis of advanced liver fibrosis and cirrhosis. J Hepatol. 2017;66:1158–1165

Article  PubMed  Google Scholar 

Xu L, Lu W, Li P, Shen F, Mi YQ, Fan JG. A comparison of hepatic steatosis index, controlled attenuation parameter and ultrasound as noninvasive diagnostic tools for steatosis in chronic hepatitis B. Dig Liver Dis. 2017;49:910–917

Article  PubMed  Google Scholar 

Liang J, Liu F, Wang F, Han T, Jing L, Ma Z, et al. A noninvasive score model for prediction of NASH in patients with chronic hepatitis B and nonalcoholic fatty liver disease. BioMed Res Int. 2017;2017:8793278

Article  PubMed  PubMed Central  Google Scholar 

Dong DR, Hao MN, Li C, Peng Z, Liu X, Wang GP, et al. Acoustic radiation force impulse elastography, FibroScan®, Forns’ index and their combination in the assessment of liver fibrosis in patients with chronic hepatitis B, and the impact of inflammatory activity and steatosis on these diagnostic methods. Mol Med Rep. 2015;11:4174–4182

Article  CAS